Suppr超能文献

BLT受体拮抗剂对大鼠肠系膜上动脉短暂缺血后局部和远隔再灌注损伤的影响。

Effects of a BLT receptor antagonist on local and remote reperfusion injuries after transient ischemia of the superior mesenteric artery in rats.

作者信息

Souza D G, Coutinho S F, Silveira M R, Cara D C, Teixeira M M

机构信息

Laboratório de Imunofarmacologia, Departamento de Bioquímica e Imunologia, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais, Av. Antonio Carlos, 6627-Pampulha, 31270-901, Minas Gerais, Belo Horizonte, Brazil.

出版信息

Eur J Pharmacol. 2000 Sep 1;403(1-2):121-8. doi: 10.1016/s0014-2999(00)00574-4.

Abstract

Reperfusion of ischemic vascular beds may lead to recruitment and activation of leukocytes, release of mediators of the inflammatory process and further injury to the affected vascular bed and to remote sites. Neutrophils appear to play a major role in the pathophysiology of reperfusion injury. Amongst inflammatory mediators shown to activate neutrophils and induce their recruitment in vivo, much interest has been placed on the role of leukotriene (LT)B(4). Here, we have assessed the effects of the BLT receptor antagonist (+)-1-(3S, 4R)-[3-(4-phenyl-benzyl)-4-hydroxy-chroman-7-yl]-cyclopentane carboxylic acid (CP 105,696) in a model of neutrophil-dependent ischemia and reperfusion injury in the rat. The superior mesenteric artery was isolated and ischemia was induced by its total occlusion for 30 min. After 30 min of reperfusion, injury was assessed by evaluating the extravasation of Evans blue, an index of vascular permeability, and the levels of myeloperoxidase, an index of neutrophil accumulation, in the intestine, mesentery and lung. The neutrophil-dependence of the local (intestine and mesentery) and remote (lung) injury was confirmed by using fucoidin, a selectin blocker, and WT-3, an anti-CD18 monoclonal antibody. Post-ischemic treatment with CP 105,696 dose-dependently inhibited vascular permeability and neutrophil accumulation in the intestine and mesentery. CP 105,696 also blocked the vascular permeability changes, but not neutrophil accumulation, in the lungs after reperfusion injury. Virtually identical results were obtained with another BLT receptor antagonist, 1-(5-ethyl-2-hydroxy-4-(6-methyl-6-(1H-tetrazol-5-yl)-heptoxy++ +)-phenyl )ethanone (LY255283). Our results suggest that post-ischemic treatment with BLT receptor antagonists may inhibit local and remote ischemia and reperfusion injury by blocking both the accumulation and/or activation of neutrophils.

摘要

缺血性血管床的再灌注可能导致白细胞的募集和激活、炎症过程介质的释放,以及对受影响血管床和远处部位的进一步损伤。中性粒细胞似乎在再灌注损伤的病理生理学中起主要作用。在已证明可激活中性粒细胞并在体内诱导其募集的炎症介质中,白三烯(LT)B4的作用备受关注。在此,我们评估了BLT受体拮抗剂(+)-1-(3S,4R)-[3-(4-苯基苄基)-4-羟基色满-7-基]-环戊烷羧酸(CP 105,696)在大鼠中性粒细胞依赖性缺血再灌注损伤模型中的作用。分离出肠系膜上动脉,通过完全闭塞30分钟诱导缺血。再灌注30分钟后,通过评估伊文思蓝的外渗(血管通透性指标)以及肠道、肠系膜和肺中髓过氧化物酶的水平(中性粒细胞积聚指标)来评估损伤。使用岩藻依聚糖(一种选择素阻滞剂)和WT-3(一种抗CD18单克隆抗体)证实了局部(肠道和肠系膜)和远处(肺)损伤对中性粒细胞的依赖性。CP 105,696缺血后治疗剂量依赖性地抑制了肠道和肠系膜中的血管通透性和中性粒细胞积聚。CP 105,696还阻断了再灌注损伤后肺中的血管通透性变化,但未阻断中性粒细胞积聚。使用另一种BLT受体拮抗剂1-(5-乙基-2-羟基-4-(6-甲基-6-(1H-四唑-5-基)-庚氧基++ +)-苯基)乙酮(LY255283)也获得了几乎相同的结果。我们的结果表明,用BLT受体拮抗剂进行缺血后治疗可能通过阻断中性粒细胞的积聚和/或激活来抑制局部和远处的缺血再灌注损伤。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验